Cell-free DNA as a Biomarker After Lung Transplantation
NCT04271267 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126
Last updated 2020-02-17
Summary
The purpose of this investigation is to determine the association of the fraction of donor-derived cell-free DNA in plasma and lung fluid samples with acute rejection as proven by biopsy in lung transplant recipients.
Conditions
- Lung Transplant Rejection
Interventions
- OTHER
-
No Intervention
Sponsors & Collaborators
-
CareDx
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Scott Palmer, MD, MHS · Duke University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-20
- Primary Completion
- 2019-11-30
- Completion
- 2019-11-30
More Related Trials
-
Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06715046 ·Status: RECRUITING
-
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
NCT00898612 ·Status: WITHDRAWN
-
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT06093867 ·Status: RECRUITING
-
Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
NCT02240381 ·Status: TERMINATED ·Phase: NA
-
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
NCT00578045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925 ·Status: RECRUITING
-
Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT01420172 ·Status: COMPLETED
-
Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
NCT02035189 ·Status: COMPLETED
-
Pulmonary Complications of Hematopoietic Stem Cell Transplantation
NCT00837681 ·Status: COMPLETED
-
Biomarkers in Transplant Recipients to Improve Outcomes
NCT01163578 ·Status: RECRUITING
-
Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation
NCT05587881 ·Status: WITHDRAWN
-
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
NCT03541889 ·Status: RECRUITING ·Phase: PHASE1
-
Immunologic Features of Respiratory Failure in Pediatric Hematopoietic Cell Transplantation (HCT) Recipients and Pediatric Oncology Patients
NCT04355780 ·Status: COMPLETED
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors
NCT04892823 ·Status: RECRUITING
-
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
NCT03500731 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia
NCT00272857 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
NCT01492036 ·Status: RECRUITING
-
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
NCT02549222 ·Status: COMPLETED
-
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
NCT01278927 ·Status: COMPLETED ·Phase: NA
-
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
NCT00281801 ·Status: COMPLETED
-
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood
NCT00143884 ·Status: TERMINATED ·Phase: PHASE2
-
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT03557749 ·Status: TERMINATED
-
Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients
NCT02776111 ·Status: TERMINATED
-
Early Detection of Endotheliopathy Post-Transplant
NCT05594251 ·Status: TERMINATED